Deals
AstraZeneca CEO says new Pfizer bid unlikely
U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca, the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business daily Dagens Industri on Saturday.
Alstom shareholders back 12.35 billion euro sale of power arm to GE
Alstom (ALSO.PA) shareholders on Friday backed with 99.2 percent of votes the French engineering group's plan to sell most of its power equipment business to General Electric (GE.N) and refocus on its smaller rail arm.
Delaware court says C&J tie up with Nabors unit can proceed
A merger between oilfield services provider C&J Energy Services Inc (CJES.N) with a unit of Nabors Industries Ltd. (NBR.N) can proceed, Delaware's supreme court ruled on Friday.
Wristband maker Fitbit in talks with banks for IPO
Fitness tracking wristband maker Fitbit Inc is in talks with banks for its initial public offering in the United States, Bloomberg reported, citing people familiar with the matter.